Replies to post #432522 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

Also, interesting is that Dr. Bosch is presenting on Jan 19

The board speculated about it would NOT be possible for NWBO and LP to get NEJM or Lancet to hold journal, until other catalysts were in place.

NEJM Evidence would make it possible, since NWBO would obviously be able to correlate with launch date, if NEJM would consider a clinical trial leading to a succesful treatment/cure to brain cancer, to be of any interest to have in place for the first issue.

So yes, that way, the Dr. Bosch presentation could have been planned to coincide with NEJM Evidence launch.

[ae kusterer]

BOSCH BOOKED TWICE IN JANUARY TO PRESENT


The Danish Dude Thursday, 01/06/22 08:47:12 AM
Re: Maverick0408 post# 432522 0
Post #
432529
of 432550
Also, interesting is that Dr. Bosch is presenting on Jan 19

The board speculated about it would NOT be possible for NWBO and LP to get NEJM or Lancet to hold journal, until other catalysts were in place.

NEJM Evidence would make it possible, since NWBO would obviously be able to correlate with launch date, if NEJM would consider a clinical trial leading to a succesful treatment/cure to brain cancer, to be of any interest to have in place for the first issue.

So yes, that way, the Dr. Bosch presentation could have been planned to coincide with NEJM Evidence launch.